The Most Exciting Month of Medical Breakthroughs in Years
Summary
Derek Thompson and Stat News writer Matthew Herper discuss a recent surge in medical breakthroughs, including Eli Lilly’s potent triple-agonist weight-loss drug retitrutide. They analyze a major pancreatic cancer advance targeting the previously "undruggable" KRAS protein and a gene-editing therapy that permanently lowers cholesterol. The conversation explores whether these developments signal a golden age of cures, the role of AI in accelerating drug discovery, and the societal challenges of access and adherence.
Topics discussed
Sponsors: ServiceNow and Indeed
Introduction: A miracle month in medicine
GLP-1 drugs: Retitrutide and broad health benefits
Pancreatic cancer breakthrough: Targeting KRAS
AI in drug development and clinical trials
Gene editing for heart disease: PCSK9 therapy
Drug pricing, access, and government incentives
Conclusion: Science funding and future outlook
Listen ad-free on Castria